Nicole LaBrosse
Director of Finance/CFO bij HALOZYME THERAPEUTICS, INC.
Vermogen: 629 726 $ op 31-03-2024
Profiel
Nicole LaBrosse is currently the Director at Antares Pharma, Inc. and the Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. She previously worked as an Auditor at PricewaterhouseCoopers LLP from 2004 to 2015.
Ms. LaBrosse has an undergraduate and graduate degree from Bentley University and a graduate degree from McCallum Graduate School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-02-2024 | 15 480 ( 0.01% ) | 629 726 $ | 31-03-2024 |
Actieve functies van Nicole LaBrosse
| Bedrijven | Functie | Begin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 02-02-2022 |
| ANTARES PHARMA, INC. | Director/Board Member | 24-05-2022 |
Eerdere bekende functies van Nicole LaBrosse
| Bedrijven | Functie | Einde |
|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01-01-2015 |
Opleiding van Nicole LaBrosse
| McCallum Graduate School of Business | Graduate Degree |
| Bentley University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
